|
The American Pharmacies Board of Directors convened September 11-12 with APRx President Laird Leavoy and his executive team to receive in-depth updates from leaders across multiple departments. The September Board Meeting focused on strategic growth, member engagement, legislative advocacy, and financial stewardship, ensuring APRx continues to strengthen its mission and support its members across the country.
Health Benefits Program
The Board approved moving forward with Invictus as the MEWA benefits provider for 2026, following the decision to terminate the current program at year-end.
Financials
Q2 2025 results were reviewed, including purchasing trends, brand WAC impacts, and the financials were unanimously approved.
Pharmacy & Clinical Services
Updates included APEX 2025, Beyond the Fill, medical billing, Clinical Services Council activities, and preferred vendor engagements. The Board discussed simplifying member choices and highlighting strategic partners.
Cencora Partnership
Cencora representatives outlined collaboration opportunities to support mutual members and explore new solutions.
Marketing & Sales
Social media, newsletter, and website enhancements were shared, along with APEX 2026 prep. Sales updates highlighted membership growth across multiple states, national account developments, and member engagement efforts.
The Board plans to meet December 4–5, 2025, with the Strategic Board Meeting on December 3.
| 
